About Ventrus Biosciences
Ventrus Biosciences is a company based in New York (United States) founded in 2005.. Ventrus Biosciences operates in a competitive market with competitors including Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2.73 M (USD), Debt – Conventional
Apr 27, 2010
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ventrus Biosciences
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $2.7M
-
First Round
First Round
(27 Apr 2010)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2010 | Amount | Debt – Conventional - Ventrus Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Ventrus Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ventrus Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ventrus Biosciences Comparisons
Competitors of Ventrus Biosciences
Ventrus Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ventrus Biosciences
When was Ventrus Biosciences founded?
Ventrus Biosciences was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Where is Ventrus Biosciences located?
Ventrus Biosciences is headquartered in New York, United States. It is registered at New York, New York, United States.
What does Ventrus Biosciences do?
Ventrus BioSciences (formerly known as South Island BioSciences) is a development stage specialty pharmaceutical company, that develops late-stage prescription drugs for gastrointestinal disorders. Pipeline include three late-stage products: Iferanserin ointment (VEN 309) for the topical treatment of hemorrhoids; Diltiazem cream (VEN 307), a topical treatment for the relief of pain associated with anal fissures; and Phenylephrine gel (VEN 308) for the treatment of fecal incontinence associated with ileal pouch anal anastomosis (IPAA). In 2014, the company merged with Assembly Pharmaceuticals and Post-merger is known as Assembly Biosciences.
Who are the top competitors of Ventrus Biosciences?
Ventrus Biosciences's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.